SlideShare a Scribd company logo
1 of 1
Download to read offline
INTRODUCTION
Figure 2: Kcnv1 Knock Down In Cortical
Neuron SliceCulture
Figure 1: Screening Of Different CRISPR
sgRNA On KCNV1 cDNAOn HEKCells
Figure 3: Comparison Of CRISPR Efficiency
In Different Systems
FUTURE DIRECTIONS
REFERENCES
1. Layer V Neurons in Mouse Cortex Projecting to Different Targets Have Distinct Physiological Properties. Alexis M. Hattox, Sacha B.
Nelson. Journal of Neurophysiology Published 1 December 2007 Vol. 98 no. 6, 3330-3340 DOI: 10.1152/jn.00397.2007
2. Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing. Heckl D,
Kowalczyk MS, Yudovich D, Belizaire R, Puram RV, McConkey ME, Thielke A, Aster JC, Regev A, Ebert BL. Nat Biotechnol. 2014 Jun 22.
doi: 10.1038/nbt.2951. 10.1038/nbt.2951
3. In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Maddalo D, Manchado E, Concepcion CP,
Bonetti C, Vidigal JA, Han YC, Ogrodowski P, Crippa A, Rekhtman N, de Stanchina E, Lowe SW, Ventura A. Nature. 2014 Dec
18;516(7531):423-7. doi: 10.1038/nature13902. Epub 2014 Oct 22. 10.1038/nature13902
1Department of Biology, Brandeis University
Maitreya Das1, Vera Valakh1 and Sacha Nelson1
Construction and Optimization of CRISPR mediated KCNV1 Knock Out Models to
Study its Phenotypiceffects on Post-mitotic Pyramidal Neurons
ACKNOWLEDGEMENTS
• Lucia Capano for Slice Culture and Molecular Cloning
• Erin Clark for FACS
sgRNA 8 showed the highest efficiency for causing a
mutation
sgRNA 8 showed relative highest efficiency, but overall
mutation efficiency was very low
• CRISPR efficiency was reduced in post
mitotic neurons
• Level of Cas9 expression may have
affected efficiency
• Sorted cells from micro-dissected Layer V
and VI showed greater mutation efficiency
may reflect inaccessibility of gene in cells
not expressing it, or dilution from cells not
expressing Cas9
• Use of multiple guides to achieve more efficient knock out
• Changing level of Cas9 expression for genomic KCNV1 (in slice culture)
• Comparing CRISPR efficiency on KCNV1 with CRISPR efficiency on a generally
expressed gene
• Two sub-types of pyramidal neurons in layer V of the
neocortex differ in their morphology, projections and
firing properties
• Adapting neurons decrease their firing rate during
constant current injection; non-adapting neurons do not.
This property is believed to result from potassium currents
that build up during repetitive firing.
• KCNV1 is an auxiliary potassium channel subunit
expressed in adapting, but not non-adapting sub-types
Non$Adapting Adapting
Hattox and Nelson 2007
• To determine whether or not KCNV1 contributes to
adaptation we aim to use CRISPR-mediated knockout in
post mitotic neurons in slice cultures from mouse cortex.

More Related Content

What's hot

A New molecular biology techniques for gene therapy
A New molecular biology techniques for gene therapyA New molecular biology techniques for gene therapy
A New molecular biology techniques for gene therapyVanessa Chappell
 
Crispr cas9 ( a overview)
Crispr cas9 ( a overview)Crispr cas9 ( a overview)
Crispr cas9 ( a overview)Navdeep Singh
 
Ubiquitination of Activation-Induced Cytidine Deaminase by RNF126 2011
Ubiquitination of Activation-Induced Cytidine Deaminase by RNF126 2011Ubiquitination of Activation-Induced Cytidine Deaminase by RNF126 2011
Ubiquitination of Activation-Induced Cytidine Deaminase by RNF126 2011Chittampalli (Yasha) N. Yashaswini
 
CRISPR: Discovery & Potential Applications
CRISPR: Discovery & Potential ApplicationsCRISPR: Discovery & Potential Applications
CRISPR: Discovery & Potential ApplicationsKumaraguru Veerasamy
 
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...Chi-Ping Day
 
CRISPR-CAS System: From Adaptive Immunity To Genome editing
CRISPR-CAS System: From Adaptive Immunity To Genome editingCRISPR-CAS System: From Adaptive Immunity To Genome editing
CRISPR-CAS System: From Adaptive Immunity To Genome editingDebanjan Pandit
 
Genome editing, luxturna
Genome editing, luxturnaGenome editing, luxturna
Genome editing, luxturnaRuqaya Anani
 
Crispr cas9 technology
Crispr cas9 technology Crispr cas9 technology
Crispr cas9 technology AshrafAlhamod
 

What's hot (20)

Dr amar Sharma
Dr amar SharmaDr amar Sharma
Dr amar Sharma
 
A New molecular biology techniques for gene therapy
A New molecular biology techniques for gene therapyA New molecular biology techniques for gene therapy
A New molecular biology techniques for gene therapy
 
CRISPER-Cas9
 CRISPER-Cas9 CRISPER-Cas9
CRISPER-Cas9
 
Crispr cas9 ( a overview)
Crispr cas9 ( a overview)Crispr cas9 ( a overview)
Crispr cas9 ( a overview)
 
CRISPR Cas9
CRISPR Cas9CRISPR Cas9
CRISPR Cas9
 
Crispar
CrisparCrispar
Crispar
 
crispr cas 9
crispr cas 9crispr cas 9
crispr cas 9
 
Crispr cas
Crispr casCrispr cas
Crispr cas
 
Ubiquitination of Activation-Induced Cytidine Deaminase by RNF126 2011
Ubiquitination of Activation-Induced Cytidine Deaminase by RNF126 2011Ubiquitination of Activation-Induced Cytidine Deaminase by RNF126 2011
Ubiquitination of Activation-Induced Cytidine Deaminase by RNF126 2011
 
CRISPR: Discovery & Potential Applications
CRISPR: Discovery & Potential ApplicationsCRISPR: Discovery & Potential Applications
CRISPR: Discovery & Potential Applications
 
CRISPR
CRISPRCRISPR
CRISPR
 
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...
Emerging Clinical Applications of CRISPR-Cas9 as Promising Strategies in Gene...
 
CRISPR
CRISPRCRISPR
CRISPR
 
Crispr cas9
Crispr cas9Crispr cas9
Crispr cas9
 
CRISPR-CAS System: From Adaptive Immunity To Genome editing
CRISPR-CAS System: From Adaptive Immunity To Genome editingCRISPR-CAS System: From Adaptive Immunity To Genome editing
CRISPR-CAS System: From Adaptive Immunity To Genome editing
 
Crispr
CrisprCrispr
Crispr
 
Crispr application
Crispr applicationCrispr application
Crispr application
 
Genome editing, luxturna
Genome editing, luxturnaGenome editing, luxturna
Genome editing, luxturna
 
CRISPR CAS9 technique
CRISPR CAS9 techniqueCRISPR CAS9 technique
CRISPR CAS9 technique
 
Crispr cas9 technology
Crispr cas9 technology Crispr cas9 technology
Crispr cas9 technology
 

Similar to Poster_Volen Retreat_Maitreya

Crispr handbook 2015
Crispr handbook 2015Crispr handbook 2015
Crispr handbook 2015rochonf
 
BrandeisBiologyREUResearchPoster_final_final
BrandeisBiologyREUResearchPoster_final_finalBrandeisBiologyREUResearchPoster_final_final
BrandeisBiologyREUResearchPoster_final_finalVictor Suarez
 
NJ Stem Cell Symposium 2011 Abstract
NJ Stem Cell Symposium 2011 AbstractNJ Stem Cell Symposium 2011 Abstract
NJ Stem Cell Symposium 2011 AbstractChristopher S Park
 
Genome editing with engineered nucleases
Genome editing with engineered nucleasesGenome editing with engineered nucleases
Genome editing with engineered nucleasesKrishan Kumar
 
Neuronal and glial differentiation of human pluripotent stem cells
Neuronal and glial differentiation of human pluripotent stem cellsNeuronal and glial differentiation of human pluripotent stem cells
Neuronal and glial differentiation of human pluripotent stem cellsDiana Santos
 
JBEI Highlights May 2016
JBEI Highlights May 2016JBEI Highlights May 2016
JBEI Highlights May 2016Irina Silva
 
Neuronal%20and%20differentiated%20cells%20lines
Neuronal%20and%20differentiated%20cells%20linesNeuronal%20and%20differentiated%20cells%20lines
Neuronal%20and%20differentiated%20cells%20lineschristinacianci
 
Genome Editing with CRISPR-Cas9
Genome Editing with CRISPR-Cas9Genome Editing with CRISPR-Cas9
Genome Editing with CRISPR-Cas9Lopamudra Nayak
 
RNA-Seq To Identify Novel Markers For Research on Neural Tissue Differentiation
RNA-Seq To Identify Novel Markers For Research on Neural Tissue DifferentiationRNA-Seq To Identify Novel Markers For Research on Neural Tissue Differentiation
RNA-Seq To Identify Novel Markers For Research on Neural Tissue DifferentiationThermo Fisher Scientific
 
CRISPR- Cas technology: a new antiviral weapon for plants
CRISPR- Cas technology: a new antiviral weapon for plantsCRISPR- Cas technology: a new antiviral weapon for plants
CRISPR- Cas technology: a new antiviral weapon for plantsSachin Bhor
 
Genome Editing CRISPR-Cas9
Genome Editing CRISPR-Cas9 Genome Editing CRISPR-Cas9
Genome Editing CRISPR-Cas9 Ek Han Tan
 
Rewriting the Genome Using CRISPR and Synthetic Biology
Rewriting the Genome Using CRISPR and Synthetic Biology Rewriting the Genome Using CRISPR and Synthetic Biology
Rewriting the Genome Using CRISPR and Synthetic Biology Integrated DNA Technologies
 
MIMG 199 P. acnes Poster Final - Lauren and Rachelle
MIMG 199 P. acnes Poster Final - Lauren and RachelleMIMG 199 P. acnes Poster Final - Lauren and Rachelle
MIMG 199 P. acnes Poster Final - Lauren and RachelleRachelle Ann Gonzales
 
Evaluating Ozoralizumab (ATN-203) as a Novel Biotherapeutic Agent for the Tre...
Evaluating Ozoralizumab (ATN-203) as a Novel Biotherapeutic Agent for the Tre...Evaluating Ozoralizumab (ATN-203) as a Novel Biotherapeutic Agent for the Tre...
Evaluating Ozoralizumab (ATN-203) as a Novel Biotherapeutic Agent for the Tre...jake9606
 

Similar to Poster_Volen Retreat_Maitreya (20)

Crispr handbook 2015
Crispr handbook 2015Crispr handbook 2015
Crispr handbook 2015
 
BrandeisBiologyREUResearchPoster_final_final
BrandeisBiologyREUResearchPoster_final_finalBrandeisBiologyREUResearchPoster_final_final
BrandeisBiologyREUResearchPoster_final_final
 
NJ Stem Cell Symposium 2011 Abstract
NJ Stem Cell Symposium 2011 AbstractNJ Stem Cell Symposium 2011 Abstract
NJ Stem Cell Symposium 2011 Abstract
 
Genome editing with engineered nucleases
Genome editing with engineered nucleasesGenome editing with engineered nucleases
Genome editing with engineered nucleases
 
Neuronal and glial differentiation of human pluripotent stem cells
Neuronal and glial differentiation of human pluripotent stem cellsNeuronal and glial differentiation of human pluripotent stem cells
Neuronal and glial differentiation of human pluripotent stem cells
 
JBEI Highlights May 2016
JBEI Highlights May 2016JBEI Highlights May 2016
JBEI Highlights May 2016
 
Neuronal%20and%20differentiated%20cells%20lines
Neuronal%20and%20differentiated%20cells%20linesNeuronal%20and%20differentiated%20cells%20lines
Neuronal%20and%20differentiated%20cells%20lines
 
Anti crispr
Anti crisprAnti crispr
Anti crispr
 
Genome Editing with CRISPR-Cas9
Genome Editing with CRISPR-Cas9Genome Editing with CRISPR-Cas9
Genome Editing with CRISPR-Cas9
 
RNA-Seq To Identify Novel Markers For Research on Neural Tissue Differentiation
RNA-Seq To Identify Novel Markers For Research on Neural Tissue DifferentiationRNA-Seq To Identify Novel Markers For Research on Neural Tissue Differentiation
RNA-Seq To Identify Novel Markers For Research on Neural Tissue Differentiation
 
ANTI-CRISPRs
ANTI-CRISPRsANTI-CRISPRs
ANTI-CRISPRs
 
CRISPR- Cas technology: a new antiviral weapon for plants
CRISPR- Cas technology: a new antiviral weapon for plantsCRISPR- Cas technology: a new antiviral weapon for plants
CRISPR- Cas technology: a new antiviral weapon for plants
 
Synaptic Transmission
Synaptic TransmissionSynaptic Transmission
Synaptic Transmission
 
Genome Editing CRISPR-Cas9
Genome Editing CRISPR-Cas9 Genome Editing CRISPR-Cas9
Genome Editing CRISPR-Cas9
 
Crisper Cas system
Crisper Cas systemCrisper Cas system
Crisper Cas system
 
Rewriting the Genome Using CRISPR and Synthetic Biology
Rewriting the Genome Using CRISPR and Synthetic Biology Rewriting the Genome Using CRISPR and Synthetic Biology
Rewriting the Genome Using CRISPR and Synthetic Biology
 
summerspowerpoint2013 (2)
summerspowerpoint2013 (2)summerspowerpoint2013 (2)
summerspowerpoint2013 (2)
 
Project.2020 ravera
Project.2020 raveraProject.2020 ravera
Project.2020 ravera
 
MIMG 199 P. acnes Poster Final - Lauren and Rachelle
MIMG 199 P. acnes Poster Final - Lauren and RachelleMIMG 199 P. acnes Poster Final - Lauren and Rachelle
MIMG 199 P. acnes Poster Final - Lauren and Rachelle
 
Evaluating Ozoralizumab (ATN-203) as a Novel Biotherapeutic Agent for the Tre...
Evaluating Ozoralizumab (ATN-203) as a Novel Biotherapeutic Agent for the Tre...Evaluating Ozoralizumab (ATN-203) as a Novel Biotherapeutic Agent for the Tre...
Evaluating Ozoralizumab (ATN-203) as a Novel Biotherapeutic Agent for the Tre...
 

Poster_Volen Retreat_Maitreya

  • 1. INTRODUCTION Figure 2: Kcnv1 Knock Down In Cortical Neuron SliceCulture Figure 1: Screening Of Different CRISPR sgRNA On KCNV1 cDNAOn HEKCells Figure 3: Comparison Of CRISPR Efficiency In Different Systems FUTURE DIRECTIONS REFERENCES 1. Layer V Neurons in Mouse Cortex Projecting to Different Targets Have Distinct Physiological Properties. Alexis M. Hattox, Sacha B. Nelson. Journal of Neurophysiology Published 1 December 2007 Vol. 98 no. 6, 3330-3340 DOI: 10.1152/jn.00397.2007 2. Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing. Heckl D, Kowalczyk MS, Yudovich D, Belizaire R, Puram RV, McConkey ME, Thielke A, Aster JC, Regev A, Ebert BL. Nat Biotechnol. 2014 Jun 22. doi: 10.1038/nbt.2951. 10.1038/nbt.2951 3. In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Maddalo D, Manchado E, Concepcion CP, Bonetti C, Vidigal JA, Han YC, Ogrodowski P, Crippa A, Rekhtman N, de Stanchina E, Lowe SW, Ventura A. Nature. 2014 Dec 18;516(7531):423-7. doi: 10.1038/nature13902. Epub 2014 Oct 22. 10.1038/nature13902 1Department of Biology, Brandeis University Maitreya Das1, Vera Valakh1 and Sacha Nelson1 Construction and Optimization of CRISPR mediated KCNV1 Knock Out Models to Study its Phenotypiceffects on Post-mitotic Pyramidal Neurons ACKNOWLEDGEMENTS • Lucia Capano for Slice Culture and Molecular Cloning • Erin Clark for FACS sgRNA 8 showed the highest efficiency for causing a mutation sgRNA 8 showed relative highest efficiency, but overall mutation efficiency was very low • CRISPR efficiency was reduced in post mitotic neurons • Level of Cas9 expression may have affected efficiency • Sorted cells from micro-dissected Layer V and VI showed greater mutation efficiency may reflect inaccessibility of gene in cells not expressing it, or dilution from cells not expressing Cas9 • Use of multiple guides to achieve more efficient knock out • Changing level of Cas9 expression for genomic KCNV1 (in slice culture) • Comparing CRISPR efficiency on KCNV1 with CRISPR efficiency on a generally expressed gene • Two sub-types of pyramidal neurons in layer V of the neocortex differ in their morphology, projections and firing properties • Adapting neurons decrease their firing rate during constant current injection; non-adapting neurons do not. This property is believed to result from potassium currents that build up during repetitive firing. • KCNV1 is an auxiliary potassium channel subunit expressed in adapting, but not non-adapting sub-types Non$Adapting Adapting Hattox and Nelson 2007 • To determine whether or not KCNV1 contributes to adaptation we aim to use CRISPR-mediated knockout in post mitotic neurons in slice cultures from mouse cortex.